Los Angeles Capital Management’s Castle Biosciences CSTL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-33,970
| Closed | -$680K | – | 1365 |
|
|
2025
Q1 | $680K | Buy |
+33,970
| New | +$680K | ﹤0.01% | 672 |
|
|
2024
Q2 | – | Sell |
-18,201
| Closed | -$403K | – | 1189 |
|
|
2024
Q1 | $403K | Hold |
18,201
| – | – | ﹤0.01% | 930 |
|
|
2023
Q4 | $393K | Sell |
18,201
-2,984
| -14% | -$64.4K | ﹤0.01% | 939 |
|
|
2023
Q3 | $358K | Buy |
+21,185
| New | +$358K | ﹤0.01% | 913 |
|
|
2023
Q2 | – | Sell |
-20,863
| Closed | -$474K | – | 1189 |
|
|
2023
Q1 | $474K | Sell |
20,863
-773
| -4% | -$17.6K | ﹤0.01% | 869 |
|
|
2022
Q4 | $509K | Sell |
21,636
-229
| -1% | -$5.39K | ﹤0.01% | 898 |
|
|
2022
Q3 | $570K | Hold |
21,865
| – | – | ﹤0.01% | 880 |
|
|
2022
Q2 | $480K | Buy |
+21,865
| New | +$480K | ﹤0.01% | 981 |
|
|
2021
Q4 | – | Sell |
-3,282
| Closed | -$218K | – | 1412 |
|
|
2021
Q3 | $218K | Hold |
3,282
| – | – | ﹤0.01% | 1403 |
|
|
2021
Q2 | $241K | Sell |
3,282
-27,496
| -89% | -$2.02M | ﹤0.01% | 1449 |
|
|
2021
Q1 | $2.11M | Sell |
30,778
-20,453
| -40% | -$1.4M | 0.01% | 604 |
|
|
2020
Q4 | $3.44M | Buy |
51,231
+3,945
| +8% | +$265K | 0.01% | 491 |
|
|
2020
Q3 | $2.43M | Buy |
47,286
+20,404
| +76% | +$1.05M | 0.01% | 517 |
|
|
2020
Q2 | $1.01M | Buy |
26,882
+6,056
| +29% | +$228K | ﹤0.01% | 842 |
|
|
2020
Q1 | $621K | Buy |
+20,826
| New | +$621K | ﹤0.01% | 841 |
|